Studies on the relationship between carotid atherosclerosis and cognitive function in subjects from the general population are few and results have been inconsistent.
Objective:
We aimed to investigate the association between carotid atherosclerotic burden and cognitive function in a cross-sectional analysis of a population-based cohort aged 63–65 years.
Methods:
All habitants born in 1950 from Akershus County, Norway were invited to participate. A linear regression model was used to assess the association between carotid atherosclerosis and cognitive function. We used carotid plaque score as a measure of carotid atherosclerotic burden and the Montreal Cognitive Assessment (MoCA) for global cognitive function.
Results:
We analyzed 3,413 individuals aged 63–65 with mean MoCA score 25.3±2.9 and 87% visible carotid plaques. We found a negative correlation between carotid plaque score and MoCA score (r = –0.14, p < 0.001), but this association was lost in multivariable analysis. In contrast, diameter or area of the thickest plaque was independently associated with MoCA score. Lower educational level, male sex, current smoking, and diabetes were also associated with lower MoCA score in multivariable analysis.
Conclusion:
Carotid atherosclerotic burden was, unlike other measures of advanced carotid atherosclerosis, not independently associated with global cognitive function.
GorelickPB, ScuteriA, BlackSE, DeCarliC, GreenbergSM, IadecolaC, LaunerLJ, LaurentS, LopezOL, NyenhuisD, PetersenRC, SchneiderJA, TzourioC, ArnettDK, BennettDA, ChuiHC, HigashidaRT, LindquistR, NilssonPM, RomanGC, SellkeFW, SeshadriS (2011) Vascular contributions to cognitive impairment and dementia a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke42, 2672–2713.
7.
CarcaillonL, PlichartM, ZureikM, RouaudO, MajedB, RitchieK, TzourioC, DartiguesJF, EmpanaJP (2015) Carotid plaque as a predictor of dementia in older adults: The Three-City Study. Alzheimers Dement11, 239–248.
8.
NewmanAB, FitzpatrickAL, LopezO, JacksonS, LyketsosC, JagustW, IvesD, DekoskyST, KullerLH (2005) Dementia and Alzheimer’s disease incidence in relationship to cardiovascular disease in the Cardiovascular Health Study cohort. J Am Geriatr Soc53, 1101–1107.
9.
WendellCR, WaldsteinSR, FerrucciL, O’BrienRJ, StraitJB, ZondermanAB (2012) Carotid atherosclerosis and prospective risk of dementia. Stroke43, 3319–3324.
10.
Hofman A1OA, BretelerMM, BotsML, SlooterAJ, van HarskampF, van DuijnCN, Van BroeckhovenC, GrobbeeDE (1997) Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer’s disease in the Rotterdam Study. Lancet349, 151–154.
11.
ArntzenKA, SchirmerH, JohnsenSH, WilsgaardT, MathiesenEB (2012) Carotid artery plaque progression and cognitive decline: The Tromso Study 1994-2008. Eur J Neurol19, 1318–1324.
12.
BakkerFC, KlijnCJ, Jennekens-SchinkelA, KappelleLJ (2000) Cognitive disorders in patients with occlusive disease of the carotid artery: A systematic review of the literature. J Neurol247, 669–676.
13.
van OijenM, de JongFJ, WittemanJC, HofmanA, KoudstaalPJ, BretelerMM (2007) Atherosclerosis and risk for dementia. Ann Neurol61, 403–410.
14.
RomeroJR, BeiserA, SeshadriS, BenjaminEJ, PolakJF, VasanRS, AuR, DeCarliC, WolfPA (2009) Carotid artery atherosclerosis, MRI indices of brain ischemia, aging, and cognitive impairment: The Framingham study. Stroke40, 1590–1596.
15.
GattoNM, HendersonVW, St JohnJA, McClearyC, DetranoR, HodisHN, MackWJ (2009) Subclinical atherosclerosis is weakly associated with lower cognitive function in healthy hyperhomocysteinemic adults without clinical cardiovascular disease. Int J Geriatr Psychiatry24, 390–399.
16.
MathiesenEB, WaterlooK, JoakimsenO, BakkeSJ, JacobsenEA, BonaaKH (2004) Reduced neuropsychological test performance in asymptomatic carotid stenosis: The Tromso Study. Neurology62, 695–701.
17.
GardenerH, CauncaMR, DongC, CheungYK, ElkindMSV, SaccoRL, RundekT, WrightCB (2017) Ultrasound markers of carotid atherosclerosis and cognition: The Northern Manhattan Study. Stroke48, 1855–1861.
18.
HanssonGK (2005) Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med352, 1685–1695.
19.
Ihle-HansenH, VigenT, Ihle-HansenH, RonningOM, BergeT, ThommessenB, LyngbakkenMN, OrstadEB, EngerS, NygårdS, RøsjøH, TveitA (2018) Prevalence of carotid plaque in a 63- to 65-year-old Norwegian cohort from the general population: The ACE (Akershus Cardiac Examination) 1950 Study. J Am Heart Assoc7, e008562.
20.
ZhongW, CruickshanksKJ, HuangGH, KleinBE, KleinR, NietoFJ, PankowJS, SchubertCR (2011) Carotid atherosclerosis and cognitive function in midlife: The Beaver Dam Offspring Study. Atherosclerosis219, 330–333.
ten KateGL, ten KateG-JR, van den OordSC, DedicA, DharampalAS, NiemanK, de FeyterPJ, SijbrandsEJ, van der SteenAF, SchinkelAF (2013) Carotid plaque burden as a measure of subclinical coronary artery disease in patients with heterozygous familial hypercholesterolemia. Am J Cardiol11, 1305–1310.
25.
NasreddineZS, PhillipsNA, BédirianV, CharbonneauS, WhiteheadV, CollinI, CummingsJL, ChertkowH (2005) The Montreal Cognitive Assessment, MoCA: A brief screening tool for mild cognitive impairment. J Am Geriatr Soc53, 695–699.
26.
PopovićIM, ŠerićV, DemarinV (2007) Mild cognitive impairment in symptomatic and asymptomatic cerebrovascular disease. J Neurol Sci257, 185–193.
27.
PiepoliMF, HoesAW, AgewallS, AlbusC, BrotonsC, CatapanoAL, CooneyMT, CorràU, CosynsB, DeatonC, GrahamI, HallMS, HobbsFDR, LøchenML, LöllgenH, Marques-VidalP, PerkJ, PrescottE, RedonJ, RichterDJ, SattarN, SmuldersY, TiberiM, van der WorpHB, van DisI, VerschurenWMM, BinnoS (2016) 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts) Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur Heart J37, 2315–2381.
28.
RydenL, GrantPJ, AnkerSD, BerneC, CosentinoF, DanchinN, DeatonC, EscanedJ, HammesHP, HuikuriH, MarreM, MarxN, MellbinL, OstergrenJ, PatronoC, SeferovicP, UvaMS, TaskinenMR, TenderaM, TuomilehtoJ, ValensiP, ZamoranoJL; ESC Committee for Practice Guidelines (CPG), ZamoranoJL, AchenbachS, BaumgartnerH, BaxJJ, BuenoH, DeanV, DeatonC, ErolC, FagardR, FerrariR, HasdaiD, HoesAW, KirchhofP, KnuutiJ, KolhP, LancellottiP, LinhartA, NihoyannopoulosP, PiepoliMF, PonikowskiP, SirnesPA, TamargoJL, TenderaM, TorbickiA, WijnsW, WindeckerS; Document Reviewers, De BackerG, SirnesPA, EzquerraEA, AvogaroA, BadimonL, BaranovaE, BaumgartnerH, BetteridgeJ, CerielloA, FagardR, Funck-BrentanoC, GulbaDC, HasdaiD, HoesAW, KjekshusJK, KnuutiJ, KolhP, LevE, MuellerC, NeysesL, NilssonPM, PerkJ, PonikowskiP, ReinerZ, SattarN, SchächingerV, ScheenA, SchirmerH, StrömbergA, SudzhaevaS, TamargoJL, ViigimaaM, VlachopoulosC, XuerebRG (2013) ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: The Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collaboration with the European Association for the Study of Diabetes (EASD). Eur Heart J34, 3035–3087.
29.
Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (2001) Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA285, 2486–2497.
30.
de Azeredo PassosVM, GiattiL, BensenorI, TiemeierH, IkramMA, de FigueiredoRC, ChorD, SchmidtMI, BarretoSM (2015) Education plays a greater role than age in cognitive test performance among participants of the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil). BMC Neurol15, 191.
31.
GanguliM, SnitzBE, LeeCW, VanderbiltJ, SaxtonJA, ChangCC (2010) Age and education effects and norms on a cognitive test battery from a population-based cohort: The Monongahela-Youghiogheny Healthy Aging Team. Aging Ment Health14, 100–107.
32.
NarazakiK, NofujiY, HondaT, MatsuoE, YonemotoK, KumagaiS (2013) Normative data for the montreal cognitive assessment in a Japanese community-dwelling older population. Neuroepidemiology40, 23–29.
33.
FotenosAF, MintunMA, SnyderAZ, MorrisJC, BucknerRL (2008) Brain volume decline in aging: Evidence for a relation between socioeconomic status, preclinical Alzheimer disease, and reserve. Arch Neurol65, 113–120.
34.
Ihle-HansenH, VigenT, BergeT, EinvikG, AarslandD, RonningOM, ThommessenB, RøsjøH, TveitA, Ihle-HansenH (2017) Montreal Cognitive Assessment in a 63- to 65-year-old Norwegian Cohort from the General Population: Data from the Akershus Cardiac Examination 1950 Study. Dement Geriatr Cogn Dis Extra7, 318–327.
35.
WendellCR, WaldsteinSR, EvansMK, ZondermanAB (2016) Subclinical carotid atherosclerosis and neurocognitive function in an urban population. Atherosclerosis249, 125–131.
36.
AuperinA, BerrC, Bonithon-KoppC, TouboulPJ, RuellandI, DucimetiereP, AlperovitchA (1996) Ultrasonographic assessment of carotid wall characteristics and cognitive functions in a community sample of 59- to 71-year-olds. The EVA Study Group. Stroke27, 1290–1295.
37.
ChenWH, JinW, LyuPY, LiuY, LiR, HuM, XiaoXJ (2017) Carotid atherosclerosis and cognitive impairment in nonstroke patients. Chin Med J (Engl)l130, 2375–2379.
38.
RaoR (2001) The role of carotid stenosis in vascular cognitive impairment. Eur Neurol46, 63–69.
39.
WaldsteinSR, WendellCR (2010) Neurocognitive function and cardiovascular disease. J Alzheimers Dis20, 833–842.
40.
TsivgoulisG, AlexandrovAV, WadleyVG, UnverzagtFW, GoRC, MoyCS, KisselaB, HowardG (2009) Association of higher diastolic blood pressure levels with cognitive impairment. Neurology73, 589–595.
PerkJ, De BackerG, GohlkeH, GrahamI, ReinerZ, VerschurenM, AlbusC, BenlianP, BoysenG, CifkovaR, DeatonC, EbrahimS, FisherM, GermanoG, HobbsR, HoesA, KaradenizS, MezzaniA, PrescottE, RydenL, SchererM, SyvänneM, Scholte op ReimerWJ, VrintsC, WoodD, ZamoranoJL, ZannadF (2012) European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Eur Heart J33, 1635–1701.
43.
RefsumH, NurkE, SmithAD, UelandPM, GjesdalCG, BjellandI, TverdalA, TellGS, NygårdO, VollsetSE (2006) The Hordaland Homocysteine Study: A community-based study of homocysteine, its determinants, and associations with disease. J Nutr136, 1731s–1740s.
44.
KrokstadS, LanghammerA, HveemK, HolmenTL, MidthjellK, SteneTR, BratbergG, HegglandJ, HolmenJ (2013) Cohort profile: The HUNT Study, Norway. Int J Epidemiol42, 968–977.
45.
GaleaS, TracyM (2007) Participation rates in epidemiologic studies. Ann Epidemiol17, 643–653.
